A genetically engineered vaccine against the alpha-toxin of Clostridium perfringens protects mice against experimental gas gangrene
about
Membrane-Binding Mechanism of Clostridium perfringens Alpha-ToxinClostridium perfringens epsilon toxin: a malevolent molecule for animals and man?Molecular and cellular basis of microvascular perfusion deficits induced by Clostridium perfringens and Clostridium septicumRecombinant Alpha, Beta, and Epsilon Toxins of Clostridium perfringens: Production Strategies and Applications as Veterinary VaccinesPresentation of protective antigen to the mouse immune system: immune sequelae.Naturally occurring Clostridium perfringens nontoxic alpha-toxin variant as a potential vaccine candidate against alpha-toxin-associated diseases.Potential role of phospholipases in virulence and fungal pathogenesis.Mapping of the continuous epitopes displayed on the Clostridium perfringens type D epsilon-toxin.Differences in the carboxy-terminal (Putative phospholipid binding) domains of Clostridium perfringens and Clostridium bifermentans phospholipases C influence the hemolytic and lethal properties of these enzymesPhospholipase region of Mycobacterium tuberculosis is a preferential locus for IS6110 transposition.Towards an understanding of the role of Clostridium perfringens toxins in human and animal disease.Perfringolysin O expression in Clostridium perfringens is independent of the upstream pfoR gene.Clostridial enteric diseases of domestic animals.Active immunization with recombinant V antigen from Yersinia pestis protects mice against plagueThe virR/virS locus regulates the transcription of genes encoding extracellular toxin production in Clostridium perfringens.Toxin-neutralizing antibodies protect against Clostridium perfringens-induced necrosis in an intestinal loop model for bovine necrohemorrhagic enteritisToxin plasmids of Clostridium perfringens.Recombinant Bacillus subtilis expressing the Clostridium perfringens alpha toxoid is a candidate orally delivered vaccine against necrotic enteritis.Technical transformation of biodefense vaccines.Alpha toxin from Clostridium perfringens induces proinflammatory changes in endothelial cells.Animal models to study the pathogenesis of human and animal Clostridium perfringens infections.Clostridial toxins.Recent progress on phospholipases: different sources, assay methods, industrial potential and pathogenicity.Highly conserved alpha-toxin sequences of avian isolates of Clostridium perfringens.Clostridium sordellii phospholipase C: gene cloning and comparison of enzymatic and biological activities with those of Clostridium perfringens and Clostridium bifermentans phospholipase CA cellular deficiency of gangliosides causes hypersensitivity to Clostridium perfringens phospholipase C.The C-terminal domain of Clostridium perfringens alpha toxin as a vaccine candidate against bovine necrohemorrhagic enteritis.Tyrosine 331 and phenylalanine 334 in Clostridium perfringens alpha-toxin are essential for cytotoxic activity.Identification of residues critical for toxicity in Clostridium perfringens phospholipase C, the key toxin in gas gangrene.UDP-glucose deficiency causes hypersensitivity to the cytotoxic effect of Clostridium perfringens phospholipase C.Variable protection against experimental broiler necrotic enteritis after immunization with the C-terminal fragment of Clostridium perfringens alpha-toxin and a non-toxic NetB variant.Induction of potential protective immunity against enterotoxemia in calves by single or multiple recombinant Clostridium perfringens toxoids.Immunization of broiler chickens against Clostridium perfringens-induced necrotic enteritis.A recombinant carboxy-terminal domain of alpha-toxin protects mice against Clostridium perfringens.A Recombinant Probiotic, Lactobacillus casei, Expressing the Clostridium perfringens α-toxoid, as an Orally Vaccine Candidate Against Gas Gangrene and Necrotic Enteritis.Generation and characterization of an inter-generic bivalent alpha domain fusion protein αCS from Clostridium perfringens and Staphylococcus aureus for concurrent diagnosis and therapeutic applications.Evaluation of the Epithelial Barrier Function and Ileal Microbiome in an Established Necrotic Enteritis Challenge Model in Broiler Chickens
P2860
Q26775008-D09B9B61-C44E-4FA9-8B88-9DCBAC8C9F35Q26859117-5DDA8FDC-6C56-4416-9932-39666A3A9B53Q27318768-A781BB2F-3F8C-4650-B47C-7CC4C6D495B3Q28067124-D47AA938-6D04-4DC6-89C7-2A166B4D8A04Q30766935-AD1ADA14-8DA4-446F-8A1D-7AFA5F97CACEQ33554674-9C78B59E-6427-4FF3-9E06-598554E64F1EQ33812431-7AF5C193-E0C2-4046-8A15-1F7A78959D5DQ33875059-E93145E7-29C7-45B0-9FB4-03AE950E9ADCQ33876481-0A1B48D9-6D9F-4E4E-A012-ECF32C43152EQ33973587-5C96F97E-840B-403E-8B5A-FBFBE31B0B21Q34139462-A8710085-B780-46CF-A206-7EF619A40495Q34308193-C550E0BD-7B3A-45D3-9D2D-A696856CAB26Q35370377-6DF78100-3AD2-4484-A40E-5639F328E501Q35426559-8D8F1E41-D7EF-4F9F-B190-6C20AB8C4B8EQ35606315-07A50CF0-C898-4997-BFEB-941B875BD5F9Q36051245-FE3075BF-E788-489B-86B1-74F6E9F39C5EQ36890396-FF0F08F7-EF3C-4E54-9B2F-983950ADF56CQ36949999-AFBB8EB4-2BD9-4082-85B6-70568E2DCCF9Q37058898-E3BA168E-C548-4518-87D4-31C689F238F9Q37370349-22AAB5C9-FEF2-40F4-8029-107AFE8947C2Q37561946-C9D57E58-4AF0-4267-A070-2C70752738A3Q37613674-56C5BB35-279D-41F6-9B8F-FF95BA377ED6Q37837714-E5762256-BC0B-4751-9FD6-22A2F194E224Q38343988-41CF7799-0E0A-4F49-A038-B0C5CA578F19Q39714393-2D51584B-8276-4A5E-8D06-9749A49E1ED7Q40416619-70289D87-FF45-4E9C-A652-DE00CE2FD8CEQ40693383-8627A868-99A7-40A8-8907-F33D51F6062BQ40808458-07A7A83B-B835-4038-9635-9FF0116E0692Q40863570-D5FDF4A8-35C3-43E8-BAEE-1410E4EEA427Q41009870-D447985C-BF07-465A-A731-DCD9D9D4A6CFQ41254006-102B6BF9-2378-4839-995E-30E1E76868FDQ41750154-8A302570-BCE6-4D81-AFC7-322AE00DC1EAQ41832193-698F9862-8AC6-4602-A844-823538491EACQ44692028-C02D9C6F-603F-4D40-966A-67257EE41F4CQ51062689-9E512970-4B96-431B-A17E-412FCC22936FQ53170697-1EE4ED44-1A5A-4BEF-A920-6724987EBD1CQ57922260-8F2EC5C8-E22C-477C-9457-7F75C160EED4
P2860
A genetically engineered vaccine against the alpha-toxin of Clostridium perfringens protects mice against experimental gas gangrene
description
1993 nî lūn-bûn
@nan
1993 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
A genetically engineered vacci ...... inst experimental gas gangrene
@ast
A genetically engineered vacci ...... inst experimental gas gangrene
@en
A genetically engineered vacci ...... inst experimental gas gangrene
@nl
type
label
A genetically engineered vacci ...... inst experimental gas gangrene
@ast
A genetically engineered vacci ...... inst experimental gas gangrene
@en
A genetically engineered vacci ...... inst experimental gas gangrene
@nl
prefLabel
A genetically engineered vacci ...... inst experimental gas gangrene
@ast
A genetically engineered vacci ...... inst experimental gas gangrene
@en
A genetically engineered vacci ...... inst experimental gas gangrene
@nl
P3181
P1433
P1476
A genetically engineered vacci ...... inst experimental gas gangrene
@en
P2093
E D Williamson
R W Titball
P304
P3181
P356
10.1016/0264-410X(93)90051-X
P407
P577
1993-09-01T00:00:00Z